85 related articles for article (PubMed ID: 6194755)
1. [Combination chemotherapy (BEAM regimen) for head and neck cancer].
Noguchi A; Inoue A; Kasai N; Uchida M
Gan To Kagaku Ryoho; 1983 Oct; 10(10):2158-62. PubMed ID: 6194755
[TBL] [Abstract][Full Text] [Related]
2. Treatment of advanced head and neck tumors with PEV-B regimen: a pilot study.
Guaraldi M; Martoni A; Rossi AP; Romagnoli D; Occhiuzzi L; Caliceti U; Pannuti F
Chemioterapia; 1988 Oct; 7(5):341-4. PubMed ID: 2465095
[TBL] [Abstract][Full Text] [Related]
3. [Combination chemotherapy with methotrexate, vincristine, cis-platinum, cyclophosphamide, adriamycin, and bleomycin: MVP-CAB for disseminated urological cancer].
Fujii A; Morishita S; Nakamura I; Oka Y; Ohshima H; Nagata H; Iwamoto T; Itoh N; Nakagawa Y; Miyazaki S
Nihon Gan Chiryo Gakkai Shi; 1990 Jan; 25(1):55-62. PubMed ID: 1691254
[TBL] [Abstract][Full Text] [Related]
4. [Combined chemotherapy for head and neck cancer using cisplatin, methotrexate and continuous subcutaneous infusion of peplomycin].
Kagami Y; Nishio M; Saitoh A; Doi Y; Asano K; Sakurai T; Murakami Y; Narimatsu N
Gan To Kagaku Ryoho; 1985 Feb; 12(2):337-42. PubMed ID: 2578770
[TBL] [Abstract][Full Text] [Related]
5. Combination chemotherapy with cisplatin, bleomycin, and methotrexate in patients with advanced head and neck cancer.
Von Hoff DD; Alberts DS; Mattox DE; Coulthard S; Dana B; Manning M; Myers JW; Griffin CB
Cancer Clin Trials; 1981; 4(2):215-8. PubMed ID: 6166408
[TBL] [Abstract][Full Text] [Related]
6. Multidrug chemotherapy using bleomycin, methotrexate, and cisplatin alone or combined with radiotherapy in advanced head and neck cancer.
Kuten A; Zidan J; Cohen Y; Robinson E
Cancer Treat Rep; 1983 Jun; 67(6):573-4. PubMed ID: 6190559
[TBL] [Abstract][Full Text] [Related]
7. Phase II study of methotrexate, vinblastine, doxorubicin, and cisplatin in patients with squamous cell carcinoma of the upper respiratory or alimentary passages of the head and neck.
Okuno SH; Mailliard JA; Suman VJ; Edmonson JH; Creagan ET; Nair S; Levitt R; Kugler JW
Cancer; 2002 Apr; 94(8):2224-31. PubMed ID: 12001121
[TBL] [Abstract][Full Text] [Related]
8. Effective outpatient combination chemotherapy for advanced cancer of the head and neck.
Chiuten D; Vogl SE; Kaplan BH; Greenwald E
Surg Gynecol Obstet; 1980 Nov; 151(5):659-62. PubMed ID: 6159692
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant chemotherapy for invasive urothelial cancer: experience with a methotrexate, vincristine, cisplatin, cyclophosphamide, adriamycin and bleomycin (MVP-CAB) regimen: a preliminary report.
Gohji K; Higuchi A; Maruyama S; Minayoshi K; Fujii A; Itoh N; Hasunuma Y; Tanaka H; Izumi T
Jpn J Clin Oncol; 1993 Oct; 23(5):291-8. PubMed ID: 7693990
[TBL] [Abstract][Full Text] [Related]
10. Combination chemotherapy for advanced non-Hodgkin's lymphomas other than diffuse histiocytic or undifferentiated histologies.
Anderson KC; Skarin AT; Rosenthal DS; MacIntyre JM; Pinkus GS; Case DC; Leonard RC; Canellos GP
Cancer Treat Rep; 1984 Nov; 68(11):1343-50. PubMed ID: 6209007
[TBL] [Abstract][Full Text] [Related]
11. Role of paclitaxel, ifosfamide, and cisplatin in patients with recurrent or metastatic squamous cell carcinoma of the head and neck.
Shin DM; Glisson BS; Khuri FR; Hong WK; Lippman SM
Semin Oncol; 1998 Apr; 25(2 Suppl 4):40-4; discussion 45-8. PubMed ID: 9578061
[TBL] [Abstract][Full Text] [Related]
12. Phase II trial of VP-16, bleomycin, and cisplatin in patients with advanced nonsquamous cell head and neck neoplasms.
Creagan ET; Schutt AJ; Richardson RL; Schaid DJ
Am J Clin Oncol; 1993 Aug; 16(4):291-4. PubMed ID: 7687089
[TBL] [Abstract][Full Text] [Related]
13. [Neo-adjuvant chemotherapy of head and neck cancer].
Bodemann H; Arnold H; Mann W; Hannich S; Kraft A; Löhr GW
Dtsch Med Wochenschr; 1986 Jul; 111(28-29):1097-100. PubMed ID: 2426076
[TBL] [Abstract][Full Text] [Related]
14. A phase I/II study of paclitaxel plus cisplatin as first-line therapy for head and neck cancers: preliminary results.
Hitt R; Hornedo J; Colomer R; Mendiola C; Brandariz A; Sevilla E; Alvarez-Vicent J; Cortés-Funes H
Semin Oncol; 1995 Dec; 22(6 Suppl 15):50-4. PubMed ID: 8643971
[TBL] [Abstract][Full Text] [Related]
15. [A study of the use of methotrexate, vincristine, cis-platinum, cyclophosphamide, adriamycin, bleomycin (MVP-CAB) in metastatic transitional cell carcinoma].
Fujii A; Den S; Nakamura I; Ohshima H; Nagata H; Izumi T; Takechi Y; Kawaida T; Kamidono S; Yasuno H
Hinyokika Kiyo; 1987 May; 33(5):697-703. PubMed ID: 2444083
[TBL] [Abstract][Full Text] [Related]
16. Bleomycin, methotrexate, and CCNU in locally advanced or recurrent, inoperable, squamous-cell carcinoma of the vulva: an EORTC Gynaecological Cancer Cooperative Group Study. European Organization for Research and Treatment of Cancer.
Wagenaar HC; Colombo N; Vergote I; Hoctin-Boes G; Zanetta G; Pecorelli S; Lacave AJ; van Hoesel Q; Cervantes A; Bolis G; Namer M; Lhommé C; Guastalla JP; Nooij MA; Poveda A; Scotto di Palumbo V; Vermorken JB
Gynecol Oncol; 2001 Jun; 81(3):348-54. PubMed ID: 11371121
[TBL] [Abstract][Full Text] [Related]
17. Primary mediastinal large B-cell lymphoma with sclerosis: a clinical study of 89 patients treated with MACOP-B chemotherapy and radiation therapy.
Zinzani PL; Martelli M; Bendandi M; De Renzo A; Zaccaria A; Pavone E; Bocchia M; Falini B; Gobbi M; Gherlinzoni F; Stefoni V; Tani M; Tura S
Haematologica; 2001 Feb; 86(2):187-91. PubMed ID: 11224489
[TBL] [Abstract][Full Text] [Related]
18. [Combined chemotherapy and radiotherapy in recurrent tumors of the head and neck region].
Tsuji H; Tsujii H; Kamada T; Takamura A; Shirato H; Matsuoka Y; Irie G
Gan To Kagaku Ryoho; 1987 Apr; 14(4):1075-8. PubMed ID: 2436578
[TBL] [Abstract][Full Text] [Related]
19. Combination chemotherapy for metastatic or locally advanced genitourinary squamous cell carcinoma: a phase II study of methotrexate, cisplatin and bleomycin.
Corral DA; Sella A; Pettaway CA; Amato RJ; Jones DM; Ellerhorst J
J Urol; 1998 Nov; 160(5):1770-4. PubMed ID: 9783949
[TBL] [Abstract][Full Text] [Related]
20. A variant of ProMACE-CytaBOM chemotherapy for non-Hodgkin's lymphoma with threefold higher drug dose size but identical cumulative dose intensity. A pilot study of the Italian lymphoma study group (GISL).
Gobbi PG; Ghirardelli ML; Avanzini P; Baldini L; Quarta G; Stelitano C; Broglia C; Loni C; Silingardi V; Ascari E
Haematologica; 2000 Mar; 85(3):263-8. PubMed ID: 10702814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
